US Stock MarketDetailed Quotes
RGLS Regulus Therapeutics
- 1.6400
- +0.1100+7.19%
Close Nov 27 16:00 ET
- 1.5900
- -0.0500-3.05%
Post 16:37 ET
107.42MMarket Cap-1607P/E (TTM)
1.6550High1.5200Low315.23KVolume1.5400Open1.5300Pre Close507.99KTurnover0.65%Turnover RatioLossP/E (Static)65.50MShares3.790052wk High1.24P/B79.81MFloat Cap1.080052wk Low--Dividend TTM48.66MShs Float3071.9974Historical High--Div YieldTTM8.82%Amplitude0.7600Historical Low1.6110Avg Price1Lot Size
Regulus Therapeutics Stock Forum
Sign in to post a comment
$Visionary Holdings (GV.US)$ $Western Digital (WDC.US)$ $Integrated Media Technology (IMTE.US)$ $Deckers Outdoor (DECK.US)$ $MediaCo (MDIA.US)$ $Skechers USA (SKX.US)$ $Regulus Therapeutics (RGLS.US)$ $Abits (ABTS.US)$ $Spark I Acquisition Corporation (SPKL.US)$ $Tapestry (TPR.US)$ $Antelope Enterprise (AEHL.US)$ $Jeffs' Brands (JFBR.US)$ $Lyell Immunopharma (LYEL.US)$ $Smart Powerr (CREG.US)$ $Bionomics (BNOX.US)$
📊⚡️📊
📊⚡️📊
6
4
$Regulus Therapeutics (RGLS.US)$ Regulus Therapeutics Inc: Remain on Track for an End of Phase 1 Meeting With FDA by End of 2024
$Regulus Therapeutics (RGLS.US)$
Regulus Therapeutics Announces Completion of Enrollment in Fourth Cohort of Phase 1b Multiple-Ascending Dose (MAD) Clinical Trial of RGLS8429 for the Treatment of Patients with Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Regulus Therapeutics Announces Completion of Enrollment in Fourth Cohort of Phase 1b Multiple-Ascending Dose (MAD) Clinical Trial of RGLS8429 for the Treatment of Patients with Autosomal Dominant Polycystic Kidney Disease (ADPKD)
$Regulus Therapeutics (RGLS.US)$ is ready Almost there.🙌
$Regulus Therapeutics (RGLS.US)$
Vanguard loaded
Vanguard loaded
So ive been asked by quite a few people that are newer traders! And because of being where we all have been. They are learning charts and where to enter and exit on momentum / day trades. But having a bit of trouble. Again as we all did and at times still do. Most know that because i cant know others risk tolerance. Or the type of trade they are doing? That i do not give buy / sell advice. But i was asked could i give some swing trade ideas, so they could have a chance to ...
49
28
![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined"){kind=small}
but you have these many holdings?
$Regulus Therapeutics (RGLS.US)$ probably going to below 1$
2
Positive Topline Data from Regulus Therapeutics' Phase 1b MAD Clinical Trial of RGLS8429 for ADPKD.
Regulus Therapeutics Inc., a biopharmaceutical company listed on Nasdaq under the ticker symbol RGLS, has recently announced positive topline results from the third cohort of patients in its Phase 1b Multiple-Ascending Dose (MAD) clinical trial of RGLS8429. This investigational drug is being developed for the treatment of ...
Regulus Therapeutics Inc., a biopharmaceutical company listed on Nasdaq under the ticker symbol RGLS, has recently announced positive topline results from the third cohort of patients in its Phase 1b Multiple-Ascending Dose (MAD) clinical trial of RGLS8429. This investigational drug is being developed for the treatment of ...
$Regulus Therapeutics (RGLS.US)$ Recovering. Gonna be a post market high or next day pre market runner. ?
1
$Regulus Therapeutics (RGLS.US)$ this chart looks like a pump and dump!?
No comment yet
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
Trademark-17 : why some your marking in red ?
Stock_Drift OP Trademark-17 : I’m not marking them, it’s a live ticker. It’s moving to the price fluctuations.
F HALE : where do i find this ticker
Trademark-17 : what your think for CREG for tomorrow?